Blog

Social Media Strategy for Diabetes & Cardiometabolic Health

by Jason Shafton

Diabetes and cardiometabolic health is among the hardest categories to navigate on social. Patients are wary, platforms enforce medical-claim rules aggressively, and generic wellness content gets lost. A social strategy that builds trust while staying within compliance lines makes the difference between a following that converts and one that simply scrolls by. We create the strategy that transforms credible health content into real patient acquisition.

The Problem

Medical claims are always one screenshot away from a platform ban or an FTC letter

Diabetes and cardiometabolic content sits in a regulated zone where an offhand claim about lowering A1C or reversing disease can trigger ad rejection, account suspension, or regulatory scrutiny. Most social teams either play it so safe the content says nothing, or they cross a line they did not know existed. Neither builds a real audience. The strategy has to be aggressive on trust and disciplined on claims at the same time, and that balance is where most brands fail.

Your audience has been burned by health influencers, so every brand is treated as a scam until it proves otherwise

People managing diabetes or heart risk have seen years of miracle-cure grifting, and they arrive on your feed with their guard up. Content that reads like a supplement pitch or a lifestyle brand gets tuned out instantly. Trust in this category is earned through demonstrated clinical substance, real patient stories that clear consent and compliance, and a consistent voice that never overpromises. Brands that skip that step build vanity followings that never convert.

Wellness-adjacent content earns likes but never brings in a patient

It is easy to rack up engagement with recipe carousels and motivational quotes, and none of it moves someone toward signing up for a program or a device. The audience that engages with soft lifestyle content is often not the audience with clinical need and buying intent. In cardiometabolic care, the person actively managing a diagnosis behaves very differently from the casual health browser. A feed optimized for reach instead of intent produces a dashboard that looks healthy and a funnel that is empty.

You post across every platform without winning on any of them

Spreading a small team across Instagram, TikTok, LinkedIn, YouTube, and X guarantees mediocre output everywhere. Each platform rewards a different format and reaches a different slice of the diabetes and cardiometabolic audience – clinicians and B2B buyers cluster on LinkedIn, patients and caregivers on Instagram and TikTok. Without a deliberate channel choice tied to who you actually need to reach, effort gets diluted into noise. Focus beats presence in this category.

How We Help

We begin by identifying who you are truly trying to reach and where they spend time. A cardiometabolic company offering a clinician-referred program has a completely different social map from a direct-to-consumer glucose product. We distinguish the patient-and-caregiver audience from the clinician-and-buyer audience, select the two channels where the right people are actually active, and avoid stretching the team across platforms that will never convert.

Next, we create the trust architecture this category requires. That means developing a claims framework with your clinical and regulatory people from the start, so the team knows precisely what can and cannot be said before anything is published. It also means highlighting genuine clinical authority – named experts, credentials, sourced content – so the feed feels credible instead of promotional. Most agencies skip this step, even though it determines whether a skeptical audience will trust you.

Then we create the content system. We establish a small set of repeatable content formats tailored to each selected platform, with every format designed to teach something specific about managing diabetes or cardiometabolic risk rather than chasing trends. A reliable system that delivers credible content every week outperforms occasional bursts of whatever is trending, and it is much easier for a lean team to maintain.

For execution, we embed within your team and manage the calendar instead of simply delivering a deck. We operate the production cadence, compliance review step, and community management a health audience expects – because a health feed that leaves comments and questions unanswered quickly loses trust. This is a fractional operator model, not an agency that vanishes once the strategy is delivered.

To measure performance, we monitor qualified follower growth, saves and shares of clinical content, plus social-sourced signups and consult bookings – not total follower counts. We assess whether the content reaches people with genuine clinical intent and whether that intent becomes a patient. Reach and vanity engagement are diagnostic at most, never the objective.

Our difference is that we operate social as an embedded growth function connected to patient acquisition and rooted in your genuine clinical substance, rather than as a content agency pursuing engagement. Social success in a skeptical, regulated health category takes someone who understands both platform dynamics and compliance realities, and we work at that intersection.

What we deliver

In diabetes and cardiometabolic health, the follower number that impresses the board is often the same one concealing an empty funnel. An audience member who saves a sourced explainer on managing A1C is worth a hundred who liked a motivational quote – and only one of those people ever becomes a patient.

Our Methodology

We deliver social media strategy through a 90-day sprint designed to establish an ongoing program. The first 30 days focus on strategy and guardrails: we map the audience, select the channels, and develop the claims framework with your clinical and regulatory team, ensuring nothing is posted until the compliance boundaries are clear. Days 30 through 60 establish the content system: we create repeatable formats for each selected platform, produce the first several weeks of credible content, and set the review-and-publish cadence. Days 60 through 90 cover operation and measurement: we run the calendar live, manage community engagement according to health-audience standards, and instrument social-sourced signups and consult bookings.

Unlike an agency retainer, we embed and operate instead of handing off a strategy deck. In a regulated category, compliance cannot be an afterthought attached to a content mill – it must be part of the production rhythm from day one. We draw on the clinical authority already present within your company, translate it into formats rewarded by each platform, and evaluate the program through qualified patient acquisition rather than follower growth.

The Insights You Want

Right in your inbox. We’ve done the work, and now we’re sharing it with you. Sign up to stay in the loop.

Get The Latest Updates


Enter your email address

How We Work

The opening 30 days establish strategy and guardrails. We map your audience, select the two channels where the right people actually spend time, and create the claims framework with your clinical and regulatory leads. You receive a clear view of why your existing social presence is or is not converting and which platforms are consuming the team's time without results.

Days 30 through 60 establish the content system. We create repeatable formats that each selected platform rewards, produce the initial weeks of content with input from your clinical team, and implement the compliance review step so publishing remains fast and safe. From your team, we require a clinical reviewer, access to your experts and patient-story pipeline, and existing brand assets.

Days 60 through 90 shift into live operation and measurement. We manage the calendar, handle community engagement at the level a health audience expects, and instrument social-sourced signups and consult bookings against your baseline. Since social compounds and community management continues, most engagements extend beyond the initial sprint into an ongoing program, with a typical initial build lasting three to six months.

Our cadence includes a weekly working session with your content and clinical leads, along with async performance updates. We work within your current content and product rhythm, allowing social to support the broader funnel instead of functioning as a separate channel.

If your diabetes & cardiometabolic health company needs social media strategy leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

What does a social media strategy engagement cost for a cardiometabolic health and diabetes company?

We charge a fixed monthly fee for social engagements, with the range determined by the program's content production needs and the level of compliance and community management your category requires. A regulated health feed involves more review overhead than a standard consumer brand, and we account for that in the scope from the outset.

How soon will we see results from a social media strategy engagement?

The content system and compliance guardrails are established during the first 90 days, and initial trust signals such as saves and qualified follows generally emerge within that period. Social-sourced signups and consult bookings grow more gradually as the audience develops trust in the feed.

How will the social media team work with our existing staff?

Rather than working as an external agency, we embed with your content, clinical, and regulatory teams. We require a clinical reviewer for compliance, access to your experts to develop credible content, and your brand assets.

How is Winston Francois different from a conventional social media agency?

A conventional agency pursues engagement and measures follower growth. We treat social as an embedded growth function, integrate the compliance framework into the production cadence so a health brand never risks a takedown, and connect the program to qualified patient acquisition rather than vanity metrics.

How is ROI measured for a social media strategy engagement?

We measure qualified follower growth, saves and shares of clinical content, and social-sourced signups and consult bookings against your pre-engagement baseline. We intentionally leave raw follower totals and vanity engagement off the scorecard because those figures can conceal an empty funnel.

What kind of diabetes and cardiometabolic health company is best suited to this service?

This service is designed for companies in roughly the 5M to 100M ARR range that have real clinical substance and the patience to develop trust through a compounding channel instead of pursuing a quick viral moment. It performs best when you can supply a clinical reviewer and access to genuine experts and patient stories. If immediate acquisition volume is your main priority, paid channels are a stronger short-term option while social grows. The process starts with a strategy call and an audit of your existing social presence.


Related Solutions

Solutions

Top Articles

Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk

Tuesday, September 22, 2026

Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk

Episode #238: Ozge Erturk – Hitting #1 in the App Store on zero paid media FloSports is profitable, covers 25+ sports, and has a million subscribers. Its CMO explains how that math works. For subscription operators, growth leads, and anyone marketing to an audience the mainstream ignores. Ozge Erturk is the CMO of FloSports, a...
Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews

Tuesday, September 15, 2026

Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews

Episode #237: Michelle Matthews – Acquisition is the easy part in health and wellness This episode is about the gap between what marketing promises and what the product delivers, and what that gap actually costs a company. For growth leaders, founders, and product teams building for people who show up on a bad day. Michelle...
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner

Tuesday, September 8, 2026

Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner

Episode #236: Elyssa Steiner – Rebuilding a 21-person marketing team in 30 days Marketing is not a lead factory. It is a growth system, and the operating model is the ceiling on what ships. For CMOs and marketing leaders who inherited a team built for a smaller company. Elyssa Steiner is Chief Marketing Officer at...
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Tuesday, June 16, 2026

Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Episode #224: Alex Roy — Bootstrapping an AI company for 12 years, no funding He founded an AI company in 2014—when AI was a punchline—bootstrapped it with zero outside capital, and landed Fortune 50 clients. For founders and growth operators figuring out how to build (and sell) AI products in a market that shifts every...

See more

Browse Categories

See more

Ready to unlock your growth?

Book Free Call

We take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.